BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 30498495)

  • 21. β-cell-specific IL-2 therapy increases islet Foxp3+Treg and suppresses type 1 diabetes in NOD mice.
    Johnson MC; Garland AL; Nicolson SC; Li C; Samulski RJ; Wang B; Tisch R
    Diabetes; 2013 Nov; 62(11):3775-84. PubMed ID: 23884888
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Macrophage migration inhibitory factor (MIF) is necessary for progression of autoimmune diabetes mellitus.
    Stosic-Grujicic S; Stojanovic I; Maksimovic-Ivanic D; Momcilovic M; Popadic D; Harhaji L; Miljkovic D; Metz C; Mangano K; Papaccio G; Al-Abed Y; Nicoletti F
    J Cell Physiol; 2008 Jun; 215(3):665-75. PubMed ID: 18064633
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduced IL-2 expression in NOD mice leads to a temporal increase in CD62Llo FoxP3+ CD4+ T cells with limited suppressor activity.
    Goudy KS; Johnson MC; Garland A; Li C; Samulski RJ; Wang B; Tisch R
    Eur J Immunol; 2011 May; 41(5):1480-1490. PubMed ID: 21469091
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Novel Liposome Formulation Carrying Both an Insulin Peptide and a Ligand for Invariant Natural Killer T Cells Induces Accumulation of Regulatory T Cells to Islets in Nonobese Diabetic Mice.
    Akimoto H; Fukuda-Kawaguchi E; Duramad O; Ishii Y; Tanabe K
    J Diabetes Res; 2019; 2019():9430473. PubMed ID: 31781669
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transient Depletion of Foxp3
    Watts D; Janßen M; Jaykar M; Palmucci F; Weigelt M; Petzold C; Hommel A; Sparwasser T; Bonifacio E; Kretschmer K
    Front Immunol; 2021; 12():720133. PubMed ID: 34447385
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methadone ameliorates multiple-low-dose streptozotocin-induced type 1 diabetes in mice.
    Amirshahrokhi K; Dehpour AR; Hadjati J; Sotoudeh M; Ghazi-Khansari M
    Toxicol Appl Pharmacol; 2008 Oct; 232(1):119-24. PubMed ID: 18671992
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy.
    Tian B; Hao J; Zhang Y; Tian L; Yi H; O'Brien TD; Sutherland DE; Hering BJ; Guo Z
    Transplantation; 2009 Jan; 87(2):198-206. PubMed ID: 19155973
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro response to interleukin-1 beta and streptozotocin in pancreatic islets isolated from male and female nonobese diabetic mice.
    Strandell E; Sandler S
    J Endocrinol; 1997 Apr; 153(1):81-6. PubMed ID: 9135572
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of the Aryl Hydrocarbon Receptor by 10-Cl-BBQ Prevents Insulitis and Effector T Cell Development Independently of Foxp3+ Regulatory T Cells in Nonobese Diabetic Mice.
    Ehrlich AK; Pennington JM; Wang X; Rohlman D; Punj S; Löhr CV; Newman MT; Kolluri SK; Kerkvliet NI
    J Immunol; 2016 Jan; 196(1):264-73. PubMed ID: 26573835
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protection against autoimmune diabetes with oral insulin is associated with the presence of IL-4 type 2 T-cells in the pancreas and pancreatic lymph nodes.
    Ploix C; Bergerot I; Fabien N; Perche S; Moulin V; Thivolet C
    Diabetes; 1998 Jan; 47(1):39-44. PubMed ID: 9421372
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 11-Keto-β-Boswellic Acids Prevent Development of Autoimmune Reactions, Insulitis and Reduce Hyperglycemia During Induction of Multiple Low-Dose Streptozotocin (MLD-STZ) Diabetes in Mice.
    Shehata AM; Quintanilla-Fend L; Bettio S; Jauch J; Scior T; Scherbaum WA; Ammon HP
    Horm Metab Res; 2015 Jun; 47(6):463-9. PubMed ID: 25951322
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antidiabetic and Immunoregulatory Activities of Extract of
    Lin CH; Kuo YH; Shih CC
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373070
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevention of multiple low-dose streptozotocin (MLD-STZ) diabetes in mice by an extract from gum resin of Boswellia serrata (BE).
    Shehata AM; Quintanilla-Fend L; Bettio S; Singh CB; Ammon HP
    Phytomedicine; 2011 Sep; 18(12):1037-44. PubMed ID: 21831620
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monocyte chemoattractant protein-1 is expressed in pancreatic islets from prediabetic NOD mice and in interleukin-1 beta-exposed human and rat islet cells.
    Chen MC; Proost P; Gysemans C; Mathieu C; Eizirik DL
    Diabetologia; 2001 Mar; 44(3):325-32. PubMed ID: 11317664
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of schistosoma mansoni egg deposition on multiple low doses streptozotocin induced insulin dependent diabetes.
    El-Wakil HS; Aboushousha TS; El Haddad O; Gamil NB; Mansour T; El-Said H
    J Egypt Soc Parasitol; 2002 Dec; 32(3):987-1002. PubMed ID: 12512830
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunization with streptozotocin-treated NOD mouse islets inhibits the onset of autoimmune diabetes in NOD mice.
    Rayat GR; Rajotte RV; Lyon JG; Dufour JM; Hacquoil BV; Korbutt GS
    J Autoimmun; 2003 Aug; 21(1):11-5. PubMed ID: 12892731
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dynamic changes of the Th17/Tc17 and regulatory T cell populations interfere in the experimental autoimmune diabetes pathogenesis.
    Yaochite JN; Caliari-Oliveira C; Davanso MR; Carlos D; Malmegrim KC; Cardoso CR; Ramalho LN; Palma PV; da Silva JS; Cunha FQ; Covas DT; Voltarelli JC
    Immunobiology; 2013 Mar; 218(3):338-52. PubMed ID: 22704522
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epigallocatechin gallate prevents autoimmune diabetes induced by multiple low doses of streptozotocin in mice.
    Song EK; Hur H; Han MK
    Arch Pharm Res; 2003 Jul; 26(7):559-63. PubMed ID: 12934649
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Administration of IL-4 prevents autoimmune diabetes but enhances pancreatic insulitis in NOD mice.
    Tominaga Y; Nagata M; Yasuda H; Okamoto N; Arisawa K; Moriyama H; Miki M; Yokono K; Kasuga M
    Clin Immunol Immunopathol; 1998 Feb; 86(2):209-18. PubMed ID: 9473384
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Newly weaned nonobese diabetic mice show heightened early diabetes sensitivity to multiple low doses of streptozotocin than nondiabetes-prone CD-1 mice: initial beta-cell damage a key trigger for type 1 diabetes?
    Reddy S; Elliott RB; Chang M; Hsu T; Rodrigues JA; Qiao L; Robinson E
    Pancreas; 2008 Jul; 37(1):e8-e19. PubMed ID: 18580436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.